通过转录学和网络药理学方法探索COPD相关骨质疏松症治疗修饰的Bu-Shen-Yi-Qi的机制
Yuanyuan Zhong1,2, Bin Wang1,2, Wenjing Chen1,2
1Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Drug design, development and therapy
|September 13, 2023
概括
修改后的Bu-Shen-Yi-Qi (MBSYQ) 有效地治疗与慢性阻塞性肺病 (COPD) 相关的骨质疏松症. 它通过改善氧代谢和激活关键信号通路来起作用,提供了一种新的治疗方法.
科学领域:
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 骨质疏松症是慢性阻塞性肺病 (COPD) 患者的重要并发症.
- 关联COPD和骨质疏松症的潜在机制是复杂的,并未完全理解.
- 目前对COPD相关的骨质疏松症的治疗方法有限.
研究的目的:
- 为了研究修改的Bu-Shen-Yi-Qi (MBSYQ) 对与COPD相关的骨质疏松症的治疗疗效.
- 阐明MBSYQ在这种条件下的作用背后的分子机制.
主要方法:
- 在MBSYQ的活性化合物,点和途径的预测.
- 通过长期暴露在香烟烟雾中,建立了COPD诱导的骨质疏松症的老鼠模型.
- 评估肺部组织病理学,骨微观结构和基因表达 (RNA测序,RT-PCR,西部斑).
- 分子对接以验证药物标相互作用.
主要成果:
- MBSYQ确定了228个治疗点,主要调节MAPK和PI3K/AKT信号通路.
- 在体内,MBSYQ减轻了肺病理,并逆转了COPD骨质疏松症大鼠的骨损失和微观结构损伤.
- MBSYQ上调了与抗氧化应激和有氧呼吸相关的基因,GSEA证实了MAPK和PI3K/AKT通路调节.
结论:
- MBSYQ在预防和治疗COPD相关的骨质疏松症方面表现出有效性.
- 治疗效益部分由改善的氧化代谢和MAPK和PI3K/AKT通路的激活介导.
相关概念视频
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K


